Free Trial

Quoin Pharmaceuticals (QNRX) SEC Filings & 10K Form

Quoin Pharmaceuticals logo
$5.48 -0.52 (-8.67%)
Closing price 04/17/2025 03:58 PM Eastern
Extended Trading
$5.49 +0.01 (+0.18%)
As of 04/17/2025 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Quoin Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/04/2025
7:30 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
11:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form POS AM
03/20/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
3:43 PM
Carter Denise P. (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/28/2025
3:44 PM
Myers Michael (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
3:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:34 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
4:20 PM
Myers Michael (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D
01/02/2025
4:20 PM
Carter Denise P. (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D
12/27/2024
4:15 PM
Culverwell Anthony James (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:16 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:16 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:17 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
8:01 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B4
12/22/2024
11:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form EFFECT
12/19/2024
8:00 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:01 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form S-1/A
12/11/2024
3:20 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
5:01 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
12/10/2024
3:45 PM
LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:46 PM
Leong Natalie Ee Mun (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:47 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:47 PM
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
SEMBER MICHAEL T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:49 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:50 PM
Culverwell Anthony James (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:51 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:52 PM
Cooper Joseph Patrick (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:23 PM
Lind Global Fund II LP (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
4:04 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
10/31/2024
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
5:15 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form ARS
10/24/2024
5:15 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form DEF 14A
10/11/2024
3:56 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form PRE 14A
09/30/2024
5:07 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:30 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
11:03 AM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
09/05/2024
11:06 AM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:32 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
06/07/2024
11:24 AM
LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:QNRX) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners